Jordan's pharmaceutical market is growing and Tabuk, being one of the top local pharmaceutical manufacturing companies in the region, is continuing its expansion in the MENA region including Jordan, where it has launched Toprazole® “Pantoprazole 40 mg Enteric Coated Tablets” in April, 2008. The total market size of anti-ulcerants in Q2 2007 was $1.2 million.
Round table discussions have been conducted to support Toprazole® launch, and to position it as the leading anti- ulcerant in the Jordanian market.